Bid Publish Date
21-Dec-2024, 1:17 pm
Bid End Date
11-Jan-2025, 2:00 pm
Location
Progress
Quantity
39
Public procurement opportunity for All India Institute Of Medical Sciences (aiims) Luxol Fast Blue MBSN pure, 2 4 Dinitro 1 naphthol, Mercury II oxide red for analysis EMSURE, Hematoxylin monohydrate, Phloxin B, SSX E5A2C Rabbit mAb Carboxy terminal Antigen, SMARCB1 BAF47 D8M1X Rabbit mAb, DDSA Specially Distilled, Propylene Oxide, Carbon Film Supported Copper Grid, Epoxy embedding medium hardener MNA, Osmium tetroxide ACS reagent in SOUTH DELHI, DELHI. Quantity: 39 issued by. Submission Deadline: 11-01-2025 14: 00: 00. View full details and respond.
Tender Category
Goods
Bid To RA
No
Item Category
Luxol Fast Blue MBSN pure , 2 4 Dinitro 1 naphthol , Mercury II oxide red for analysis EMSURE , Hematoxylin monohydrate , Phloxin B , SSX E5A2C Rabbit mAb Carboxy terminal Antigen , SMARCB1 BAF47 D8M1X Rabbit mAb , DDSA Specially Distilled , Propylene Oxide , Carbon Film Supported Copper Grid , Epoxy embedding medium hardener MNA , Osmium tetroxide ACS reagent
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Luxol Fast Blue MBSN pure
As per Specification Sheet
2 4 Dinitro 1 naphthol
As per Specification Sheet
Mercury II oxide red for analysis EMSURE
As per Specification Sheet
Hematoxylin monohydrate
As per Specification Sheet
Phloxin B
As per Specification Sheet
SSX E5A2C Rabbit mAb Carboxy terminal Antigen
As per Specification Sheet
SMARCB1 BAF47 D8M1X Rabbit mAb
As per Specification Sheet
DDSA Specially Distilled
As per Specification Sheet
Propylene Oxide
As per Specification Sheet
Carbon Film Supported Copper Grid
As per Specification Sheet
Epoxy embedding medium hardener MNA
As per Specification Sheet
Osmium tetroxide ACS reagent
As per Specification Sheet
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Luxol Fast Blue MBSN pure | As per Specification Sheet | 2 | 25gm | 777096 | 30 | |
| 2 | 2 4 Dinitro 1 naphthol | As per Specification Sheet | 2 | 25gm | 777096 | 30 | |
| 3 | Mercury II oxide red for analysis EMSURE | As per Specification Sheet | 4 | 50gm | 777096 | 30 | |
| 4 | Hematoxylin monohydrate | As per Specification Sheet | 10 | 25gm | 777096 | 30 | |
| 5 | Phloxin B | As per Specification Sheet | 4 | 25gm | 777096 | 30 | |
| 6 | SSX E5A2C Rabbit mAb Carboxy terminal Antigen | As per Specification Sheet | 1 | 100ul | 777096 | 30 | |
| 7 | SMARCB1 BAF47 D8M1X Rabbit mAb | As per Specification Sheet | 1 | 100ul | 777096 | 30 | |
| 8 | DDSA Specially Distilled | As per Specification Sheet | 4 | 450ml | 777096 | 30 | |
| 9 | Propylene Oxide | As per Specification Sheet | 2 | 1ltr | 777096 | 30 | |
| 10 | Carbon Film Supported Copper Grid | As per Specification Sheet | 5 | 1box | 777096 | 30 | |
| 11 | Epoxy embedding medium hardener MNA | As per Specification Sheet | 2 | 250ml | 777096 | 30 | |
| 12 | Osmium tetroxide ACS reagent | As per Specification Sheet | 2 | 1gm | 777096 | 30 |
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | BIOLOGICAL SHOP Under PMA | - | 09-01-2025 22:00:37 | |
| 2 | SSK LABS PRIVATE LIMITED Under PMA | - | 10-01-2025 19:59:05 |
| Rank | Seller | Price | Item |
|---|---|---|---|
| L1 | SSK LABS PRIVATE LIMITED(MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : Luxol Fast Blue MBSN pure,2 4 Dinitro 1 naphthol,Mercury II oxide red for analysis EMSURE,Hematoxyl | |
| L2 | BIOLOGICAL SHOP (MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : Luxol Fast Blue MBSN pure,2 4 Dinitro 1 naphthol,Mercury II oxide red for analysis EMSURE,Hematoxyl |
Key insights about DELHI tender market
The eligibility requirements include being a registered entity, having a minimum average annual turnover of ₹3 lakh for the past three years, and possessing at least three years of experience in supplying similar products to government or public sector organizations.
Yes, bidders must provide various required certificates, including audited financial statements, proof of previous contracts, and any specific compliance or certification documents required in the tender documentation.
The registration process involves submitting digitally signed documents through the e-Governance platform, ensuring all required documentation is included as outlined in the bid announcement.
Documents must be submitted in common formats, such as PDF and Word files, ensuring they comply with any specifications mentioned in the bid documents.
The technical specifications for the materials are thoroughly detailed in the bid document, covering aspects such as purity, composition, and performance metrics relevant to laboratory usage.
All materials procured through this tender must comply with quality standards outlined by the relevant statutory bodies and requisites specified in the tender documentation.
Yes, bidders must ensure compliance with the ’Make in India’ policy, which requires a minimum local content percentage as defined in the tender, hence qualifying as a local supplier may impact bid preference.
The tender specifically states that EMD is not required to participate in this tender. However, bidders should check the latest updates as conditions may vary.
Bidders are not required to submit any performance security for this bid, facilitating ease of participation.
The payment terms will be outlined in the bid documents, detailing conditions under which payments will be processed upon delivery and successful inspection of the products.
Price evaluations will be conducted based on competitive pricing as well as compliance with technical requirements defined in the tender submissions, ensuring value for the government entity.
Bidders are required to submit their proposals electronically via the e-Governance platform, ensuring all necessary documents are included.
Key timelines and deadlines for submission are provided in the bid announcement; however, the specifics are generally communicated based on the tender lifecycle.
The evaluation process will be based on technical compliance, financial stability, and past performance, leading to a selection decision communicated through the governing body of the tender.
Results will be communicated officially through the e-Governance platform after the evaluation process is complete. Bidders should ensure they provide accurate contact information for effective communication.
MSEs benefit from preferential treatment in evaluating bids, which includes reduced criteria for financial turnover and experience requirements under specified conditions.
Startups may get certain exemptions from general eligibility criteria; however, these stipulations are specifically detailed within the tender documents.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS